NCT06922591
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06922591
Title Study to Evaluate the Safety, Tolerability & Efficacy of TNG462 in Combination in PDAC & NSCLC Patients
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements Yes
Sponsors Tango Therapeutics, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Mayo Clinic Scottsdale RECRUITING Scottsdale Arizona 85259-5452 United States Details
Sarah Cannon Research Institute Denver RECRUITING Denver Colorado 80218 United States Details
Mayo Clinic Jacksonville RECRUITING Jacksonville Florida 32224 United States Details
University of Indiana RECRUITING Indianapolis Indiana 46202 United States Details
Dana-Farber Cancer Institute RECRUITING Boston Massachusetts 02115 United States Details
Mayo Clinic Cancer Center RECRUITING Rochester Minnesota 55905-0001 United States Details
Nebraska Cancer Specialists RECRUITING Omaha Nebraska 68124 United States Details
NYU Langone Health RECRUITING New York New York 10016 United States Details
Memorial Sloan Kettering Cancer Center RECRUITING New York New York 11065 United States Details
University of Texas MD Anderson Cancer Center RECRUITING Houston Texas 77030 United States Details
NEXT Dallas RECRUITING Irving Texas 74039 United States Details
NEXT Oncology RECRUITING Fairfax Virginia 22031 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field